Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Boswell

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
The Journal of Experimental Medicine|January 29, 2014
Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variantsNga Bien-Ly, Y Joy Yu, Daniela Bumbaca, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 9, 2012
Differential effects of predosing on tumor and tissue uptake of an 111In-labeled anti-TENB2 antibody-drug conjugateC Andrew Boswell, Eduardo E Mundo, Crystal Zhang, et al.
Mabs|December 18, 2014
Framework selection can influence pharmacokinetics of a humanized therapeutic antibody through differences in molecule chargeBing Li, Devin Tesar, C Andrew Boswell, et al.
Neuron|October 24, 2015
Lack of Widespread BBB Disruption in Alzheimer's Disease Models: Focus on Therapeutic AntibodiesNga Bien-Ly, C Andrew Boswell, Surinder Jeet, et al.
Molecular Cancer Therapeutics|February 7, 2020
Effect of Modulating FcRn Binding on Direct and Pretargeted Tumor Uptake of Full-length AntibodiesLidia Nazarova, Hanine Rafidi, Danielle Mandikian, et al.
Mabs|February 28, 2014
Quantitative cumulative biodistribution of antibodies in mice: effect of modulating binding affinity to the neonatal Fc receptorVictor Yip, Enzo Palma, Devin B Tesar, et al.
British Journal of Pharmacology|November 15, 2011
Maximizing tumour exposure to anti-neuropilin-1 antibody requires saturation of non-tumour tissue antigenic sinks in miceDaniela Bumbaca, Hong Xiang, C Andrew Boswell, et al.
Mabs|December 9, 2014
Dose dependent pharmacokinetics, tissue distribution, and anti-tumor efficacy of a humanized monoclonal antibody against DLL4 in miceAmrita V Kamath, Victor Yip, Priyanka Gupta, et al.
Oncotarget|November 7, 2019
Biodistribution and efficacy of an anti-TENB2 antibody-drug conjugate in a patient-derived model of prostate cancerC Andrew Boswell, Daniela Bumbaca Yadav, Eduardo E Mundo, et al.
Scientific Reports|May 31, 2018
Antibody-mediated stabilization of NRG1 induces behavioral and electrophysiological alterations in adult miceSara L Dominguez, Ganapati V Hegde, Jesse E Hanson, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
The Journal of Experimental Medicine|January 29, 2014
Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variantsNga Bien-Ly, Y Joy Yu, Daniela Bumbaca, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 9, 2012
Differential effects of predosing on tumor and tissue uptake of an 111In-labeled anti-TENB2 antibody-drug conjugateC Andrew Boswell, Eduardo E Mundo, Crystal Zhang, et al.
Mabs|December 18, 2014
Framework selection can influence pharmacokinetics of a humanized therapeutic antibody through differences in molecule chargeBing Li, Devin Tesar, C Andrew Boswell, et al.
Neuron|October 24, 2015
Lack of Widespread BBB Disruption in Alzheimer's Disease Models: Focus on Therapeutic AntibodiesNga Bien-Ly, C Andrew Boswell, Surinder Jeet, et al.
Molecular Cancer Therapeutics|February 7, 2020
Effect of Modulating FcRn Binding on Direct and Pretargeted Tumor Uptake of Full-length AntibodiesLidia Nazarova, Hanine Rafidi, Danielle Mandikian, et al.
Mabs|February 28, 2014
Quantitative cumulative biodistribution of antibodies in mice: effect of modulating binding affinity to the neonatal Fc receptorVictor Yip, Enzo Palma, Devin B Tesar, et al.
British Journal of Pharmacology|November 15, 2011
Maximizing tumour exposure to anti-neuropilin-1 antibody requires saturation of non-tumour tissue antigenic sinks in miceDaniela Bumbaca, Hong Xiang, C Andrew Boswell, et al.
Mabs|December 9, 2014
Dose dependent pharmacokinetics, tissue distribution, and anti-tumor efficacy of a humanized monoclonal antibody against DLL4 in miceAmrita V Kamath, Victor Yip, Priyanka Gupta, et al.
Oncotarget|November 7, 2019
Biodistribution and efficacy of an anti-TENB2 antibody-drug conjugate in a patient-derived model of prostate cancerC Andrew Boswell, Daniela Bumbaca Yadav, Eduardo E Mundo, et al.
Scientific Reports|May 31, 2018
Antibody-mediated stabilization of NRG1 induces behavioral and electrophysiological alterations in adult miceSara L Dominguez, Ganapati V Hegde, Jesse E Hanson, et al.
Pageof 7